Boise-based Albertsons Companies, Inc., reported a net loss in its fourth quarter due to a nearly $774 million charge related to an opioid settlement, even as the grocery giant posted full-year net income and announced a dividend increase and expanded share buyback program Monday.
At a Glance:
- Albertsons posts $774 million opioid settlement charge
- Full-year net income of $217 million reported
- Board raises dividend 13% and expands buyback to $2 billion
The company reported a fourth-quarter net loss of $481 million, or 94 cents per share, for the 13 weeks ending Feb. 28, 2026. The loss was driven by a $773.8 million charge ― $599.8 million after taxes ― tied to an opioid settlement framework intended to resolve claims brought by states, political subdivisions, and Native American tribes. Payments under the settlement are expected to be spread over nine years.
Stripping out the opioid charge and other items, adjusted net income for the quarter was $252 million, or 48 cents per share. Adjusted EBITDA came in at $903 million, up from $855 million in the same period a year earlier…